GB:BTEC Holdings Information

Name: GB:BTEC Holdings - iShares NASDAQ US Biotechnology UCITS ETF
Creator: TipRanks
License: https://www.tipranks.com/terms

Last updated: October 9, 2026

Holdings Count

247

Total Assets

1.14B

Top 10 Percentage

46.00%

Asset Class

Equity

Top Holdings

247 Holdings as of Oct 09, 2026

Name	Weight %	Market Value	Price & Change	Market Cap	Yearly Gain	Analyst Consensus	Analyst Price Target
GILD Gilead Sciences	8.41%	$102.74M	―	$187.44B	27.88%	17 Buy 4 Hold 0 Sell Strong Buy	―
AMGN Amgen Inc	7.91%	$96.64M	―	$224.29B	41.88%	9 Buy 16 Hold 2 Sell Moderate Buy	―
VRTX Vertex Pharmaceuticals Inc.	7.72%	$94.30M	―	$129.29B	25.21%	21 Buy 3 Hold 0 Sell Strong Buy	―
MRNA Moderna	5.38%	$65.74M	―	$89.83B	699.33%	3 Buy 14 Hold 3 Sell Hold	―
REGN Regeneron Pharmaceuticals	5.12%	$62.51M	―	$76.86B	33.85%	14 Buy 8 Hold 0 Sell Moderate Buy	―
RVMD Revolution Medicines, Inc.	2.76%	$33.71M	―	$40.67B	293.37%	22 Buy 1 Hold 0 Sell Strong Buy	―
ILMN Illumina	2.73%	$33.39M	―	$42.00B	192.72%	8 Buy 4 Hold 3 Sell Moderate Buy	―
BIIB Biogen Inc.	2.21%	$26.98M	―	$33.35B	55.99%	17 Buy 6 Hold 1 Sell Moderate Buy	―
ALNY Alnylam Pharmaceuticals	2.06%	$25.15M	―	$31.13B	-49.95%	18 Buy 4 Hold 0 Sell Strong Buy	―
RPRX Royalty Pharma PLC	1.71%	$20.92M	―	$32.74B	63.04%	7 Buy 0 Hold 0 Sell Strong Buy	―